SCHEMBL7184850

SCHEMBL7184850

CN(C)C(=O)c1ccc(C(=O)/C=C/c2c(OC(C)(C)C)cccc2OC(C)(C)C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.58
MAOA P21397 2/20 0.44
LMNA P02545 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
HPGD P15428 3/20 0.43
ATM Q13315 2/20 0.43
ALOX12 P18054 1/20 0.43
MAPT P10636 4/20 0.42
NPC1 O15118 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RECQL P46063 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
MAOB P27338 3/20 0.41
ALDH1A1 P00352 1/20 0.41
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184854 1.00 ABCG2 (0.58) ABCG2MAOALMNASMN1; SMN2HPGD
SCHEMBL9202149 0.87 MAPT (0.55) ABCG2LMNASMN1; SMN2HPGDATM
SCHEMBL9202156 0.87 MAPT (0.55) ABCG2LMNASMN1; SMN2HPGDATM
SCHEMBL7185686 0.86 ABCG2 (0.80) ABCG2MAOALMNAHPGDMAPT
SCHEMBL7185692 0.86 ABCG2 (0.80) ABCG2MAOALMNAHPGDMAPT
SCHEMBL7185831 0.85 ABCG2 (0.63) ABCG2MAOAMAPTCYP3A4MAOB
SCHEMBL7185827 0.85 ABCG2 (0.63) ABCG2MAOAMAPTCYP3A4MAOB
SCHEMBL7178729 0.84 ABCG2 (0.40) ABCG2MAOALMNASMN1; SMN2HPGD
SCHEMBL7178727 0.84 ABCG2 (0.40) ABCG2MAOALMNASMN1; SMN2HPGD
SCHEMBL7803088 0.83 ABCG2 (0.61) ABCG2MAOALMNASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed